Rifamycin
Records for this ingredient, by country (identity only).
ATC J04AB · 4 markets · 45 records
CN 39 records · 5 shown of 5
- 250 mg per mL / per unit basis not statedinjection星索宁利福霉素澜琪、赛瑞辰、Manufacturer: 哈尔滨三联药业股份有限公司、Manufacturer: 哈尔滨医大药业股份有限公司、Manufacturer: 沈阳双鼎制药有限公司、Manufacturer: 西藏安星医药有限公司、Manufacturer: 辅仁药业集团有限公司
- 250 mg/5 mLinjectionManufacturer: 哈尔滨医大药业股份有限公司 ×6Manufacturer: 成都第一制药有限公司、Manufacturer: 沈阳双鼎制药有限公司、Manufacturer: 海南倍特药业有限公司、Manufacturer: 辅仁药业集团有限公司
- 125 mg/2 mLinjectionManufacturer: 成都第一制药有限公司 ×2Manufacturer: 沈阳双鼎制药有限公司、Manufacturer: 河南辅仁怀庆堂制药有限公司、Manufacturer: 海南倍特药业有限公司
- 500 mg/10 mLinjectionManufacturer: 哈尔滨医大药业股份有限公司 ×6Manufacturer: 沈阳双鼎制药有限公司
- 500 mg per mL / per unit basis not statedinjection星索宁利福霉素
FR 3 records · 3 shown of 3
- 2600 mg/100 mLliquidOTOFA, solution auriculaire en gouttes
- 0 IU per mL / per unit basis not statedliquidRIFAMYCINE CHIBRET 1000 000 UI POUR CENT, collyre en solution
- 1,000,000 IU/100 gtopicalRIFAMYCINE CHIBRET 1 000 000 UI/100 g, pommade ophtalmique
ES 1 records · 1 shown of 1
- 200 mgtablet · modified-releaseRIFAMICINA ADALVO
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
Also called: 利福霉素钠、利福黴素類 nickname
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.